ARCH Venture Fund X, L.P.

ARCH Venture Fund X, L.P. insider trades: Aspen Neuroscience (ASPE) stock purchases

Aspen Neuroscience Last trade Nov 2, 2026 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$20.0M
Bought, last 12 months
2 buys
9
Open-market trades
since 2022
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where ARCH Venture Fund X, L.P. reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026ASPE↑ Buy$18.0M
Nov 2, 2026ASPE↑ Buy$2.0M
Oct 27, 2025NMRA↑ Buy$5.0M
Aug 1, 2025PRME↑ Buy$10.0M
Feb 15, 2024PRME↑ Buy$20.0M
Feb 8, 2024SANA↑ Buy$6.0M
Sep 19, 2023NMRA↑ Buy$25.5M
Oct 24, 2022PRME↑ Buy$6.8M
Oct 24, 2022PRME↑ Buy$6.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ASPE insiders

Open-market trades in the last 12 months

About ARCH Venture Fund X, L.P.'s insider trades

ARCH Venture Fund X, L.P. is an insider at Aspen Neuroscience (ASPE). Since Oct 24, 2022, it has reported 9 open-market purchases worth $100.1M and no sales on SEC Form 4. In the last 12 months: 2 buys ($20.0M).

Its filings also include conversions (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ASPE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.